CompaniesAcuity Pharmaceuticals

Acuity Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

340

By Phase

PHASE1/PHASE2: 3PHASE1: 1

By Status

COMPLETED: 3SUSPENDED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT03366480
NCT03417921
NCT04431258
Hover over trial bars to see details

Recent Trials

NCT04431258Lead Sponsor
ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study
PHASE1/PHASE2Completed
150 participants
Started: May 6, 2021 · Completed: Jan 10, 2024
NCT03417921Lead Sponsor
A Study of ABTL0812 in Pancreatic Cancer
PHASE1/PHASE2Suspended
60 participants
Started: Apr 26, 2021 · Completed: Dec 31, 2025
NCT03366480Lead Sponsor
A Study to Assess the Efficacy and Safety of ABTL0812
PHASE1/PHASE2Completed
103 participants
Started: Dec 1, 2016 · Completed: Nov 15, 2020
NCT02201823Lead Sponsor
Phase I/Ib Clinical Trial of ABTL0812 in Advanced Cancer Patients
PHASE1Completed
27 participants
Started: Feb 28, 2014 · Completed: Apr 30, 2015
Related Companies
Froptix And Exegenics To Become Opko Health Mar 2007----------------------------------------if You Believe Any Of This Information Is Incorrect
merged